Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy
暂无分享,去创建一个
Stefan Neubauer | Matthew D Robson | Stefan K Piechnik | Lowri Cochlin | Rajarshi Banerjee | M. Robson | S. Piechnik | S. Neubauer | V. Ferreira | H. Watkins | C. Holloway | R. Banerjee | T. Karamitsos | L. Cochlin | Sairia Dass | Masliza Mahmod | Hugh Watkins | Theodoros D Karamitsos | Cameron J Holloway | M. Mahmod | J. Suttie | S. Dass | Vanessa M Ferreira | Joseph J Suttie | Sairia Dass
[1] A. Flett,et al. Characterising the myocardial interstitial space: the clinical relevance of non-invasive imaging , 2012, Heart.
[2] 杜昕,et al. Inherited cardiomyopathies , 2012 .
[3] S. K. White,et al. Age and gender dependence of pre-contrast T1-relaxation times in normal human myocardium at 1.5T using ShMOLLI , 2012, Journal of Cardiovascular Magnetic Resonance.
[4] S. Neubauer,et al. Exercise Acutely Exacerbates Derangement Of Cardiac Energy Metabolism In Hypertrophic Cardiomyopathy, a 31 Phosphorus Magnetic Resonance Study at 3 Telsa , 2011 .
[5] M. Pasque,et al. Magnetic resonance imaging detects significant sex differences in human myocardial strain , 2011, Biomedical engineering online.
[6] Pierre Croisille,et al. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. , 2011, Journal of the American College of Cardiology.
[7] Vivek Muthurangu,et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. , 2011, JACC. Cardiovascular imaging.
[8] M. Cheitlin,et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .
[9] H. Watkins,et al. Inherited cardiomyopathies. , 2011, The New England journal of medicine.
[10] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[11] B. Byrne,et al. Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. , 2010, Circulation.
[12] S. Colan,et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. , 2010, The New England journal of medicine.
[13] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[14] M. Sheppard,et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .
[15] A. Tajik,et al. Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[16] M. Robson,et al. Reproducibility of 31P cardiac magnetic resonance spectroscopy at 3 T , 2009, NMR in biomedicine.
[17] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[18] D. Graveron-Demilly,et al. Java-based graphical user interface for the MRUI quantitation package , 2001, Magnetic Resonance Materials in Physics, Biology and Medicine.
[19] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[20] Christine E Seidman,et al. A Contemporary Approach to Hypertrophic Cardiomyopathy , 2006, Circulation.
[21] David C. Sheridan,et al. Resting Myocardial Blood Flow Is Impaired in Hibernating Myocardium: A Magnetic Resonance Study of Quantitative Perfusion Assessment , 2005, Circulation.
[22] Stefan Neubauer,et al. Ultrashort TE chemical shift imaging (UTE‐CSI) , 2005, Magnetic resonance in medicine.
[23] Erik G. Ellsworth,et al. Prevalence and Spectrum of Thin Filament Mutations in an Outpatient Referral Population With Hypertrophic Cardiomyopathy , 2003, Circulation.
[24] A. Blamire,et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. , 2003, Journal of the American College of Cardiology.
[25] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[26] P. Elliott,et al. Role of genotyping in risk factor assessment for sudden death in hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[27] J. Towbin,et al. The failing heart , 2002, Nature.
[28] U Ravens,et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology. , 2001, European heart journal.
[29] R. de Beer,et al. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals , 2001, Comput. Biol. Medicine.
[30] R Pohmann,et al. Accurate phosphorus metabolite images of the human heart by 3D acquisition‐weighted CSI , 2001, Magnetic resonance in medicine.
[31] C. Brilla,et al. Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease , 2000, Circulation.
[32] B. Strauer,et al. Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease. , 2000, Hypertension.
[33] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[34] M. Laser,et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. , 1995, The Journal of clinical investigation.
[35] P A Bottomley,et al. Optimum flip‐angles for exciting NMR with uncertain T1 values , 1994, Magnetic resonance in medicine.
[36] S. Neubauer,et al. 31P Magnetic Resonance Spectroscopy in Dilated Cardiomyopathy and Coronary Artery Disease: Altered Cardiac High‐Energy Phosphate Metabolism in Heart Failure , 1992, Circulation.
[37] K. Weber,et al. Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.